Clinical Trials Directory

Trials / Conditions / CML, Chronic Phase

CML, Chronic Phase

11 registered clinical trials studyying CML, Chronic Phase — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingPEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML
NCT06409936
Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 2
Not Yet RecruitingStudy of HS-10382 Combination in Patients With Chronic Myeloid Leukemia (CML)
NCT06530810
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1
RecruitingStudy of Olverembatinib (HQP1351) in Patients With CP-CML
NCT06423911
Ascentage Pharma Group Inc.Phase 3
UnknownMetabolic Alternation and Clinicohematological Characteristic in Chronic Phase CML in Patient Treated With TKI
NCT06121765
Assiut University—
Not Yet RecruitingA Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed C
NCT05367765
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 4
RecruitingA Study of HS-10382 in Patients With Chronic Myeloid Leukemia.
NCT05367700
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1
UnknownA Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in
NCT05353205
Jiangsu Hansoh Pharmaceutical Co., Ltd.Phase 4
CompletedPrecision Dosing of Tyrosine Kinase Inhibitors in CML Patients
NCT03885830
UNC Lineberger Comprehensive Cancer Center—
RecruitingA Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Pre
NCT03459534
Il-Yang Pharm. Co., Ltd.Phase 3
CompletedValue of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
NCT04883125
Mansoura UniversityPhase 2
UnknownStudy to Assess Efficacy and Safety of Inecalcitol in Imatinib-Treated Residual Chronic Myeloid Leukaemia: INI
NCT02949570
Hybrigenics CorporationPhase 2